New product launches are one of the key trends being observed in the blastomycosis market
The Azoles segment generated the maximum revenue in 2021
North America dominated the blastomycosis market in 2021
The blastomycosis market was valued at $177.16 million in 2021, and is estimated to reach $257.71 million by 2031, growing at a CAGR of 3.8% from 2022 to 2031.
Abbott, Astellas Pharma, and Cipla are a few major companies to occupy a major share of the Blastomycosis Market.
Growth in the population with antifungal drug resistance coupled with presence of counterfeit drugs restricts the growth of the Blastomycosis Market.
LAMEA is the fastest-growing region in the Blastomycosis Market
Loading Table Of Content...
Enter Valid Email ID
Verification code has been sent to your email ID
Advantages Of Our Secure Login
Easily Track Orders, Hassel free Access, Downloads
Get Relevent Alerts and Recommendation
Wishlist, Coupons & Manage your Subscription
Register and Earn 500 Loyalty Points
Have a Referral Code?
Enter Valid Referral Code
An Email Verification Code has been sent to your email address!
Please check your inbox and, if you don't find it there, also look in your junk folder.
Global Opportunity Analysis and Industry Forecast, 2021-2031